Sign-up for a FREE trial here. Genentech, a member of the Roche Group (OTC: RHHBY) announced positive results for TECENTRIQ from the Phase III study, OAK. The study met its co-primary endpoints and showed a statistically …
Figure 1: DNLI stock chart. (Source: StockCharts ... Denali was founded by three superstars from Genentech: Ryan Watts (former Director of Dept. of Neuroscience at Genentech, now CEO and President at Denali), Alex Schuth (former …
Bruce E. Johnson, MD, FASCO Dana-Farber Cancer Institute Disclosures: …
About PeptiDream Inc. PeptiDream Inc. is a public (Tokyo Stock Exchange First Section 4587 ... Teijin, Kyorin, Ipsen, Genentech, Shionogi, Asahi Kasei, Janssen, and Bayer, all of which are active and ongoing. In addition, PeptiDream …
LOS ANGELES, Aug. 12— Shares of Genentech Inc., the nation's largest biotechnology company, dropped today to their lowest level this year amid speculation that the company's heart attack drug, Activase, may face tough competition …
NEW YORK (CNNMoney.com) - Genentech's stock jumped more than 5 percent on Friday after the biotech said its earnings would surge by up to 50 percent in 2006. The biotech, based in South San Francisco, also said it expects to …
Since Roche announced its intention to buy the outstanding shares of Genentech, everbody’s been wondering whether the company’s top scientists will bolt. Genentech put a retention plan in place yesterday — but the main payouts would …
Exelixis stock dropped 14.5% after the biotech company gave a negative update on one of its candidate treatments. Exelixis had been working with Roche Group's …
said it settled litigation with Genentech and Tercica regarding the growth-deficiency treatment Iplex, and will have to slash its work force as a result. Insmed's (down $0.60 to $0.95, Charts) stock price plunged 46 percent following the news. …